Citigroup
BIOA

Citigroup’s BioAmber Inc. BIOA Stock Holding History

Citigroup’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-44
Closed – – 7707
2016
Q1 		$0 Buy
44
+38
+633% +$159 ﹤0.01% 8002
2015
Q4 		$0 Buy
+6
New +$45 ﹤0.01% 8081
2015
Q3 		– Sell
-38
Closed – – 8021
2015
Q2 		$0 Buy
38
+28
+280% +$256 ﹤0.01% 7936
2015
Q1 		$0 Buy
+10
New +$88 ﹤0.01% 7604

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $4.73B AUM 58.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Citigroup's BIOA Position: Q2 2016 in Review

Citigroup sold out of BioAmber Inc. (BIOA) in Q2 2016, closing a stake of 44 shares.

Citigroup first reported a position in BIOA in Q1 2015 and held it in 4 quarters. The position peaked at $0 in Q1 2016. 33 funds tracked by Wall St. Rank hold BIOA as of Q2 2016.

  • Citigroup reported no remaining BioAmber Inc. position as of Q2 2016 after selling out during the quarter.
  • Citigroup sold 44 BioAmber Inc. shares in Q2 2016.
  • Citigroup first reported a position in BioAmber Inc. in Q1 2015 and held it in 4 quarters.
  • Citigroup's BioAmber Inc. position peaked at $0 in Q1 2016.
  • 33 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.